INTRODUCTION
Delay of nidation of blastocysts is a phenomenon which occurs naturally and regularly in some wild species of mammals (Eckstein, Shelesnyak & Amoroso, 1959) . It also occurs in pregnant, lactating laboratory rats and mice (Enzmann, Saphir & Pincus, 1932; Mayer, 1959) . The condition can be induced experi¬ mentally in rats by ovariectomy and treatment with progesterone after fertilization but before implantation has occurred. Animals treated in this way will retain blastocysts free in the uterus in a viable condition for long periods of time or until they are induced to implant by oestrogen administration. This procedure has been described by Cochrane & Meyer (1957) from this laboratory as well as by other investigators.
Delayed nidation can be induced experimentally in rats by auto-grafting the anterior pituitary gland to the kidney capsule on the 2nd day of pregnancy (Cochrane, Prasad & Meyer, 1962) . In these animals also, nidation is delayed until the blastocysts are induced to implant by treatment with oestrogen.
There are no reports in the literature of implantation being delayed in intact rats by the administration of progesterone alone. Progesterone at a single daily dose of 16 mg (Cochrane & Meyer, 1957) We have found that blastocysts are maintained in the delayed condition for extended periods. We have flushed the uteri of MAP-treated animals and recovered blastocysts 45 days after insemination. A low-power microscopic examination of such blastocysts shows them to be similar to late, pre-implantation blastocysts from untreated, pregnant rats.
We have initiated nidation after a long period of delay by the administration of oestrone 32 days after insemination, but no foetuses survived to the day of autopsy. However, when the delay period is shorter, i.e. when oestrone is begun either 20 or 15 days after insemination, approximately 20% of the foetuses survived.
DISCUSSION
The mechanism by which map causes delay of implantation in intact rats is being studied. The substance is known to be a powerful progestational agent as determined by proliferation of rabbit uterine endometrium, and it has also been shown to inhibit ovulation in the rabbit when administered orally or parenterally at doses much lower than progesterone itself (Barnes, Schmidt & Dulin, 1959) . This latter action is believed to be due to map preventing the release of L. E. Barnes and R. K. Meyer LH which is necessary for pre-ovulatory follicular swelling and ovulation, map also has the ability to prevent the so-called 'castration hypersécrétion' of gonadotrophins from the pituitary of the castrate partner of rats in parabiosis (Shipley, 1962 Stucki (1958) has shown that doses of map up to 20 mg/day beginning on Day 8 of pregnancy, had no apparent deleterious effect on the survival of young in ovariectomized pregnant rats. This would indicate that the low rates of survival of foetuses from rats receiving high doses of map in this present experiment were due to some factor other than a direct toxicity of the compound or that the effect was greater prior to Day 8. Unlike Stucki's work, in which map was administered only after implantation had been accomplished, in our work all events of pregnancy took place in an environment influenced by this compound, so that there was opportunity for it to exert more striking effects upon the pregnancies.
The survival of blastocysts in map delay provides a means for study, in the intact rat, of blastocyst-uterine relationships in implantation. Use of the mapdelayed implantation in the rat has been described recently by Duncan & Lyster (1963) for their studies of an anti-oestrogenic compound and its effects on blastocyst survival.
